nodes	percent_of_prediction	percent_of_DWPC	metapath
Alogliptin—CYP2D6—breast cancer	0.232	0.538	CbGaD
Alogliptin—CYP3A4—breast cancer	0.199	0.462	CbGaD
Alogliptin—CYP3A4—Exemestane—breast cancer	0.046	0.103	CbGbCtD
Alogliptin—CYP2D6—Idarubicin—breast cancer	0.0415	0.093	CbGbCtD
Alogliptin—CYP3A4—Letrozole—breast cancer	0.0391	0.0876	CbGbCtD
Alogliptin—CYP3A4—Anastrozole—breast cancer	0.0348	0.0781	CbGbCtD
Alogliptin—CYP3A4—Toremifene—breast cancer	0.0319	0.0714	CbGbCtD
Alogliptin—CYP3A4—Fulvestrant—breast cancer	0.0296	0.0664	CbGbCtD
Alogliptin—CYP3A4—Thiotepa—breast cancer	0.0264	0.0592	CbGbCtD
Alogliptin—CYP3A4—Ixabepilone—breast cancer	0.0241	0.0541	CbGbCtD
Alogliptin—CYP3A4—Lapatinib—breast cancer	0.0232	0.0521	CbGbCtD
Alogliptin—CYP2D6—Vinorelbine—breast cancer	0.0203	0.0454	CbGbCtD
Alogliptin—CYP2D6—Tamoxifen—breast cancer	0.0183	0.041	CbGbCtD
Alogliptin—CYP3A4—Raloxifene—breast cancer	0.0176	0.0395	CbGbCtD
Alogliptin—CYP3A4—Vinorelbine—breast cancer	0.0129	0.0289	CbGbCtD
Alogliptin—CYP2D6—Vinblastine—breast cancer	0.0125	0.028	CbGbCtD
Alogliptin—CYP3A4—Tamoxifen—breast cancer	0.0116	0.0261	CbGbCtD
Alogliptin—CYP3A4—Mitoxantrone—breast cancer	0.0113	0.0254	CbGbCtD
Alogliptin—Acute hepatic failure—Ixabepilone—breast cancer	0.00906	0.112	CcSEcCtD
Alogliptin—CYP3A4—Paclitaxel—breast cancer	0.00906	0.0203	CbGbCtD
Alogliptin—CYP3A4—Irinotecan—breast cancer	0.00893	0.02	CbGbCtD
Alogliptin—CYP3A4—Vinblastine—breast cancer	0.00794	0.0178	CbGbCtD
Alogliptin—CYP2D6—Doxorubicin—breast cancer	0.00768	0.0172	CbGbCtD
Alogliptin—CYP3A4—Docetaxel—breast cancer	0.00655	0.0147	CbGbCtD
Alogliptin—CYP3A4—Doxorubicin—breast cancer	0.00488	0.0109	CbGbCtD
Alogliptin—Linagliptin—CYP3A4—breast cancer	0.00174	0.546	CrCbGaD
Alogliptin—Pancreatitis acute—Paclitaxel—breast cancer	0.00146	0.018	CcSEcCtD
Alogliptin—Linagliptin—ABCB1—breast cancer	0.00145	0.454	CrCbGaD
Alogliptin—Diabetes mellitus—Raloxifene—breast cancer	0.00136	0.0167	CcSEcCtD
Alogliptin—Anaphylactic shock—Fluoxymesterone—breast cancer	0.00121	0.0149	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Exemestane—breast cancer	0.00112	0.0138	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Ixabepilone—breast cancer	0.00106	0.0131	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Anastrozole—breast cancer	0.00095	0.0117	CcSEcCtD
Alogliptin—Diabetes mellitus—Goserelin—breast cancer	0.000934	0.0115	CcSEcCtD
Alogliptin—Erythema multiforme—Exemestane—breast cancer	0.000915	0.0113	CcSEcCtD
Alogliptin—Hypersensitivity—Fluoxymesterone—breast cancer	0.000893	0.011	CcSEcCtD
Alogliptin—Angioedema—Fulvestrant—breast cancer	0.000886	0.0109	CcSEcCtD
Alogliptin—Erythema multiforme—Ixabepilone—breast cancer	0.000863	0.0106	CcSEcCtD
Alogliptin—Anaphylactic shock—Lapatinib—breast cancer	0.000861	0.0106	CcSEcCtD
Alogliptin—Erythema multiforme—Anastrozole—breast cancer	0.000813	0.01	CcSEcCtD
Alogliptin—Erythema multiforme—Letrozole—breast cancer	0.000813	0.01	CcSEcCtD
Alogliptin—Headache—Fluoxymesterone—breast cancer	0.000759	0.00936	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Chlorambucil—breast cancer	0.00073	0.009	CcSEcCtD
Alogliptin—Pancreatitis—Tamoxifen—breast cancer	0.000721	0.00888	CcSEcCtD
Alogliptin—Angioedema—Letrozole—breast cancer	0.000684	0.00843	CcSEcCtD
Alogliptin—Angioedema—Anastrozole—breast cancer	0.000684	0.00843	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Goserelin—breast cancer	0.000652	0.00804	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Tamoxifen—breast cancer	0.00065	0.00801	CcSEcCtD
Alogliptin—Hypersensitivity—Lapatinib—breast cancer	0.000634	0.00782	CcSEcCtD
Alogliptin—Urticaria—Fulvestrant—breast cancer	0.000629	0.00775	CcSEcCtD
Alogliptin—Erythema multiforme—Chlorambucil—breast cancer	0.000625	0.0077	CcSEcCtD
Alogliptin—DPP4—embryo—breast cancer	0.000623	0.125	CbGeAlD
Alogliptin—Pancreatitis—Vinorelbine—breast cancer	0.000616	0.0076	CcSEcCtD
Alogliptin—Anaphylactic shock—Letrozole—breast cancer	0.000611	0.00753	CcSEcCtD
Alogliptin—Anaphylactic shock—Anastrozole—breast cancer	0.000611	0.00753	CcSEcCtD
Alogliptin—Hypersensitivity—Fulvestrant—breast cancer	0.000583	0.00719	CcSEcCtD
Alogliptin—Anaphylactic shock—Idarubicin—breast cancer	0.00058	0.00715	CcSEcCtD
Alogliptin—Erythema multiforme—Tamoxifen—breast cancer	0.000556	0.00686	CcSEcCtD
Alogliptin—Urticaria—Exemestane—breast cancer	0.000546	0.00673	CcSEcCtD
Alogliptin—Rash—Lapatinib—breast cancer	0.000543	0.00669	CcSEcCtD
Alogliptin—Dermatitis—Lapatinib—breast cancer	0.000542	0.00668	CcSEcCtD
Alogliptin—Headache—Lapatinib—breast cancer	0.000539	0.00665	CcSEcCtD
Alogliptin—Angioedema—Chlorambucil—breast cancer	0.000526	0.00648	CcSEcCtD
Alogliptin—Nasopharyngitis—Fluorouracil—breast cancer	0.000514	0.00633	CcSEcCtD
Alogliptin—DPP4—epithelium—breast cancer	0.000508	0.102	CbGeAlD
Alogliptin—Pancreatitis—Irinotecan—breast cancer	0.000508	0.00627	CcSEcCtD
Alogliptin—Hypersensitivity—Exemestane—breast cancer	0.000506	0.00624	CcSEcCtD
Alogliptin—Hypoglycaemia—Paclitaxel—breast cancer	0.000501	0.00618	CcSEcCtD
Alogliptin—Rash—Fulvestrant—breast cancer	0.000499	0.00615	CcSEcCtD
Alogliptin—Dermatitis—Fulvestrant—breast cancer	0.000499	0.00615	CcSEcCtD
Alogliptin—Headache—Fulvestrant—breast cancer	0.000496	0.00611	CcSEcCtD
Alogliptin—Rash—Toremifene—breast cancer	0.000493	0.00607	CcSEcCtD
Alogliptin—Dermatitis—Toremifene—breast cancer	0.000492	0.00607	CcSEcCtD
Alogliptin—Headache—Toremifene—breast cancer	0.000489	0.00603	CcSEcCtD
Alogliptin—Urticaria—Anastrozole—breast cancer	0.000485	0.00598	CcSEcCtD
Alogliptin—Urticaria—Letrozole—breast cancer	0.000485	0.00598	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Mitoxantrone—breast cancer	0.000482	0.00594	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Irinotecan—breast cancer	0.000482	0.00594	CcSEcCtD
Alogliptin—Hypersensitivity—Ixabepilone—breast cancer	0.000478	0.00589	CcSEcCtD
Alogliptin—Angioedema—Tamoxifen—breast cancer	0.000468	0.00577	CcSEcCtD
Alogliptin—Diabetes mellitus—Capecitabine—breast cancer	0.000462	0.00569	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Fluorouracil—breast cancer	0.000462	0.00569	CcSEcCtD
Alogliptin—Urticaria—Idarubicin—breast cancer	0.000461	0.00568	CcSEcCtD
Alogliptin—DPP4—endometrium—breast cancer	0.000456	0.0918	CbGeAlD
Alogliptin—Hypersensitivity—Anastrozole—breast cancer	0.00045	0.00555	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Gemcitabine—breast cancer	0.000447	0.0055	CcSEcCtD
Alogliptin—Nasopharyngitis—Paclitaxel—breast cancer	0.000438	0.00539	CcSEcCtD
Alogliptin—Rash—Exemestane—breast cancer	0.000433	0.00534	CcSEcCtD
Alogliptin—Dermatitis—Exemestane—breast cancer	0.000433	0.00534	CcSEcCtD
Alogliptin—Headache—Exemestane—breast cancer	0.000431	0.00531	CcSEcCtD
Alogliptin—Hypersensitivity—Idarubicin—breast cancer	0.000427	0.00526	CcSEcCtD
Alogliptin—DPP4—uterus—breast cancer	0.00042	0.0846	CbGeAlD
Alogliptin—Pancreatitis—Paclitaxel—breast cancer	0.000415	0.00511	CcSEcCtD
Alogliptin—DPP4—adipose tissue—breast cancer	0.000411	0.0827	CbGeAlD
Alogliptin—Anaphylactic shock—Melphalan—breast cancer	0.000409	0.00504	CcSEcCtD
Alogliptin—Rash—Ixabepilone—breast cancer	0.000409	0.00504	CcSEcCtD
Alogliptin—Dermatitis—Ixabepilone—breast cancer	0.000409	0.00504	CcSEcCtD
Alogliptin—Headache—Ixabepilone—breast cancer	0.000406	0.00501	CcSEcCtD
Alogliptin—Angioedema—Vinorelbine—breast cancer	0.0004	0.00493	CcSEcCtD
Alogliptin—Anaphylactic shock—Goserelin—breast cancer	0.000399	0.00492	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Paclitaxel—breast cancer	0.000393	0.00485	CcSEcCtD
Alogliptin—Rash—Anastrozole—breast cancer	0.000385	0.00475	CcSEcCtD
Alogliptin—Rash—Letrozole—breast cancer	0.000385	0.00475	CcSEcCtD
Alogliptin—Dermatitis—Letrozole—breast cancer	0.000385	0.00474	CcSEcCtD
Alogliptin—Dermatitis—Anastrozole—breast cancer	0.000385	0.00474	CcSEcCtD
Alogliptin—Headache—Anastrozole—breast cancer	0.000383	0.00472	CcSEcCtD
Alogliptin—Headache—Letrozole—breast cancer	0.000383	0.00472	CcSEcCtD
Alogliptin—Erythema multiforme—Gemcitabine—breast cancer	0.000382	0.00471	CcSEcCtD
Alogliptin—DPP4—female reproductive system—breast cancer	0.000378	0.076	CbGeAlD
Alogliptin—Stevens-Johnson syndrome—Paclitaxel—breast cancer	0.000374	0.00461	CcSEcCtD
Alogliptin—Urticaria—Chlorambucil—breast cancer	0.000373	0.0046	CcSEcCtD
Alogliptin—Nasopharyngitis—Docetaxel—breast cancer	0.000371	0.00457	CcSEcCtD
Alogliptin—DPP4—adrenal gland—breast cancer	0.000369	0.0742	CbGeAlD
Alogliptin—Rash—Raloxifene—breast cancer	0.000366	0.00451	CcSEcCtD
Alogliptin—Rash—Idarubicin—breast cancer	0.000366	0.00451	CcSEcCtD
Alogliptin—Dermatitis—Idarubicin—breast cancer	0.000365	0.0045	CcSEcCtD
Alogliptin—Dermatitis—Raloxifene—breast cancer	0.000365	0.0045	CcSEcCtD
Alogliptin—Headache—Raloxifene—breast cancer	0.000363	0.00448	CcSEcCtD
Alogliptin—Headache—Idarubicin—breast cancer	0.000363	0.00448	CcSEcCtD
Alogliptin—Nasopharyngitis—Capecitabine—breast cancer	0.000359	0.00443	CcSEcCtD
Alogliptin—Anaphylactic shock—Vinorelbine—breast cancer	0.000358	0.00441	CcSEcCtD
Alogliptin—DPP4—bone marrow—breast cancer	0.000357	0.0718	CbGeAlD
Alogliptin—Hypersensitivity—Chlorambucil—breast cancer	0.000346	0.00426	CcSEcCtD
Alogliptin—Diabetes mellitus—Methotrexate—breast cancer	0.000344	0.00424	CcSEcCtD
Alogliptin—DPP4—female gonad—breast cancer	0.000344	0.0692	CbGeAlD
Alogliptin—Urticaria—Tamoxifen—breast cancer	0.000332	0.00409	CcSEcCtD
Alogliptin—Urticaria—Melphalan—breast cancer	0.000325	0.00401	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Capecitabine—breast cancer	0.000323	0.00398	CcSEcCtD
Alogliptin—Diabetes mellitus—Epirubicin—breast cancer	0.000322	0.00396	CcSEcCtD
Alogliptin—Erythema multiforme—Paclitaxel—breast cancer	0.00032	0.00395	CcSEcCtD
Alogliptin—DPP4—endocrine gland—breast cancer	0.00032	0.0643	CbGeAlD
Alogliptin—Urticaria—Goserelin—breast cancer	0.000317	0.00391	CcSEcCtD
Alogliptin—Hypersensitivity—Vinblastine—breast cancer	0.000317	0.00391	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.000317	0.00391	CcSEcCtD
Alogliptin—Hypersensitivity—Tamoxifen—breast cancer	0.000308	0.0038	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.000307	0.00378	CcSEcCtD
Alogliptin—Hypersensitivity—Melphalan—breast cancer	0.000302	0.00372	CcSEcCtD
Alogliptin—Diabetes mellitus—Doxorubicin—breast cancer	0.000298	0.00367	CcSEcCtD
Alogliptin—Anaphylactic shock—Mitoxantrone—breast cancer	0.000295	0.00364	CcSEcCtD
Alogliptin—Anaphylactic shock—Irinotecan—breast cancer	0.000295	0.00364	CcSEcCtD
Alogliptin—Hypersensitivity—Goserelin—breast cancer	0.000294	0.00363	CcSEcCtD
Alogliptin—Anaphylactic shock—Gemcitabine—breast cancer	0.000287	0.00354	CcSEcCtD
Alogliptin—Hypoglycaemia—Epirubicin—breast cancer	0.000287	0.00353	CcSEcCtD
Alogliptin—Urticaria—Vinorelbine—breast cancer	0.000284	0.0035	CcSEcCtD
Alogliptin—Anaphylactic shock—Fluorouracil—breast cancer	0.000282	0.00348	CcSEcCtD
Alogliptin—Erythema multiforme—Docetaxel—breast cancer	0.000271	0.00334	CcSEcCtD
Alogliptin—Urticaria—Thiotepa—breast cancer	0.000271	0.00334	CcSEcCtD
Alogliptin—Headache—Vinblastine—breast cancer	0.00027	0.00332	CcSEcCtD
Alogliptin—Angioedema—Paclitaxel—breast cancer	0.000269	0.00332	CcSEcCtD
Alogliptin—Hypoglycaemia—Doxorubicin—breast cancer	0.000265	0.00327	CcSEcCtD
Alogliptin—Rash—Tamoxifen—breast cancer	0.000264	0.00325	CcSEcCtD
Alogliptin—Hypersensitivity—Vinorelbine—breast cancer	0.000263	0.00325	CcSEcCtD
Alogliptin—Dermatitis—Tamoxifen—breast cancer	0.000263	0.00325	CcSEcCtD
Alogliptin—Erythema multiforme—Capecitabine—breast cancer	0.000263	0.00324	CcSEcCtD
Alogliptin—Headache—Tamoxifen—breast cancer	0.000262	0.00323	CcSEcCtD
Alogliptin—Rash—Melphalan—breast cancer	0.000258	0.00318	CcSEcCtD
Alogliptin—Dermatitis—Melphalan—breast cancer	0.000258	0.00318	CcSEcCtD
Alogliptin—Pancreatitis—Methotrexate—breast cancer	0.000253	0.00312	CcSEcCtD
Alogliptin—Rash—Goserelin—breast cancer	0.000252	0.0031	CcSEcCtD
Alogliptin—Hypersensitivity—Thiotepa—breast cancer	0.000252	0.0031	CcSEcCtD
Alogliptin—Dermatitis—Goserelin—breast cancer	0.000251	0.0031	CcSEcCtD
Alogliptin—Nasopharyngitis—Epirubicin—breast cancer	0.00025	0.00308	CcSEcCtD
Alogliptin—Headache—Goserelin—breast cancer	0.00025	0.00308	CcSEcCtD
Alogliptin—Anaphylactic shock—Paclitaxel—breast cancer	0.000241	0.00296	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Methotrexate—breast cancer	0.00024	0.00296	CcSEcCtD
Alogliptin—Pancreatitis—Epirubicin—breast cancer	0.000237	0.00292	CcSEcCtD
Alogliptin—Urticaria—Mitoxantrone—breast cancer	0.000234	0.00289	CcSEcCtD
Alogliptin—Nasopharyngitis—Doxorubicin—breast cancer	0.000231	0.00285	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000228	0.00282	CcSEcCtD
Alogliptin—Rash—Vinorelbine—breast cancer	0.000225	0.00278	CcSEcCtD
Alogliptin—Dermatitis—Vinorelbine—breast cancer	0.000225	0.00278	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Epirubicin—breast cancer	0.000225	0.00277	CcSEcCtD
Alogliptin—Urticaria—Fluorouracil—breast cancer	0.000224	0.00277	CcSEcCtD
Alogliptin—Headache—Vinorelbine—breast cancer	0.000224	0.00276	CcSEcCtD
Alogliptin—DPP4—lymph node—breast cancer	0.000221	0.0445	CbGeAlD
Alogliptin—Pancreatitis—Doxorubicin—breast cancer	0.000219	0.0027	CcSEcCtD
Alogliptin—Hypersensitivity—Irinotecan—breast cancer	0.000217	0.00268	CcSEcCtD
Alogliptin—Hypersensitivity—Mitoxantrone—breast cancer	0.000217	0.00268	CcSEcCtD
Alogliptin—Rash—Thiotepa—breast cancer	0.000215	0.00265	CcSEcCtD
Alogliptin—Dermatitis—Thiotepa—breast cancer	0.000215	0.00265	CcSEcCtD
Alogliptin—Headache—Thiotepa—breast cancer	0.000214	0.00264	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000214	0.00263	CcSEcCtD
Alogliptin—Hypersensitivity—Fluorouracil—breast cancer	0.000208	0.00256	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000208	0.00256	CcSEcCtD
Alogliptin—Anaphylactic shock—Docetaxel—breast cancer	0.000204	0.00251	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000198	0.00244	CcSEcCtD
Alogliptin—Erythema multiforme—Methotrexate—breast cancer	0.000196	0.00241	CcSEcCtD
Alogliptin—Urticaria—Paclitaxel—breast cancer	0.000191	0.00236	CcSEcCtD
Alogliptin—Rash—Mitoxantrone—breast cancer	0.000186	0.00229	CcSEcCtD
Alogliptin—Rash—Irinotecan—breast cancer	0.000186	0.00229	CcSEcCtD
Alogliptin—Dermatitis—Mitoxantrone—breast cancer	0.000186	0.00229	CcSEcCtD
Alogliptin—Dermatitis—Irinotecan—breast cancer	0.000186	0.00229	CcSEcCtD
Alogliptin—Headache—Irinotecan—breast cancer	0.000185	0.00228	CcSEcCtD
Alogliptin—Headache—Mitoxantrone—breast cancer	0.000185	0.00228	CcSEcCtD
Alogliptin—Erythema multiforme—Epirubicin—breast cancer	0.000183	0.00226	CcSEcCtD
Alogliptin—Rash—Gemcitabine—breast cancer	0.000181	0.00223	CcSEcCtD
Alogliptin—Dermatitis—Gemcitabine—breast cancer	0.000181	0.00223	CcSEcCtD
Alogliptin—Headache—Gemcitabine—breast cancer	0.00018	0.00222	CcSEcCtD
Alogliptin—Rash—Fluorouracil—breast cancer	0.000178	0.0022	CcSEcCtD
Alogliptin—Dermatitis—Fluorouracil—breast cancer	0.000178	0.00219	CcSEcCtD
Alogliptin—Hypersensitivity—Paclitaxel—breast cancer	0.000177	0.00218	CcSEcCtD
Alogliptin—Headache—Fluorouracil—breast cancer	0.000177	0.00218	CcSEcCtD
Alogliptin—Erythema multiforme—Doxorubicin—breast cancer	0.000169	0.00209	CcSEcCtD
Alogliptin—Urticaria—Capecitabine—breast cancer	0.000157	0.00193	CcSEcCtD
Alogliptin—Rash—Paclitaxel—breast cancer	0.000152	0.00187	CcSEcCtD
Alogliptin—Dermatitis—Paclitaxel—breast cancer	0.000152	0.00187	CcSEcCtD
Alogliptin—Headache—Paclitaxel—breast cancer	0.000151	0.00186	CcSEcCtD
Alogliptin—Hypersensitivity—Docetaxel—breast cancer	0.00015	0.00185	CcSEcCtD
Alogliptin—Anaphylactic shock—Methotrexate—breast cancer	0.000147	0.00181	CcSEcCtD
Alogliptin—Hypersensitivity—Capecitabine—breast cancer	0.000145	0.00179	CcSEcCtD
Alogliptin—Anaphylactic shock—Epirubicin—breast cancer	0.000138	0.00169	CcSEcCtD
Alogliptin—Rash—Docetaxel—breast cancer	0.000129	0.00158	CcSEcCtD
Alogliptin—Dermatitis—Docetaxel—breast cancer	0.000128	0.00158	CcSEcCtD
Alogliptin—Headache—Docetaxel—breast cancer	0.000128	0.00157	CcSEcCtD
Alogliptin—Anaphylactic shock—Doxorubicin—breast cancer	0.000127	0.00157	CcSEcCtD
Alogliptin—Rash—Capecitabine—breast cancer	0.000124	0.00153	CcSEcCtD
Alogliptin—Dermatitis—Capecitabine—breast cancer	0.000124	0.00153	CcSEcCtD
Alogliptin—Headache—Capecitabine—breast cancer	0.000124	0.00152	CcSEcCtD
Alogliptin—CYP3A4—female reproductive system—breast cancer	0.000123	0.0248	CbGeAlD
Alogliptin—CYP2D6—female reproductive system—breast cancer	0.000121	0.0244	CbGeAlD
Alogliptin—Urticaria—Methotrexate—breast cancer	0.000117	0.00144	CcSEcCtD
Alogliptin—CYP2D6—female gonad—breast cancer	0.00011	0.0222	CbGeAlD
Alogliptin—Urticaria—Epirubicin—breast cancer	0.000109	0.00135	CcSEcCtD
Alogliptin—Hypersensitivity—Methotrexate—breast cancer	0.000108	0.00133	CcSEcCtD
Alogliptin—CYP3A4—endocrine gland—breast cancer	0.000104	0.021	CbGeAlD
Alogliptin—CYP2D6—endocrine gland—breast cancer	0.000103	0.0206	CbGeAlD
Alogliptin—Hypersensitivity—Epirubicin—breast cancer	0.000101	0.00125	CcSEcCtD
Alogliptin—Urticaria—Doxorubicin—breast cancer	0.000101	0.00125	CcSEcCtD
Alogliptin—Hypersensitivity—Doxorubicin—breast cancer	9.37e-05	0.00116	CcSEcCtD
Alogliptin—Rash—Methotrexate—breast cancer	9.26e-05	0.00114	CcSEcCtD
Alogliptin—Dermatitis—Methotrexate—breast cancer	9.26e-05	0.00114	CcSEcCtD
Alogliptin—Headache—Methotrexate—breast cancer	9.2e-05	0.00113	CcSEcCtD
Alogliptin—Rash—Epirubicin—breast cancer	8.67e-05	0.00107	CcSEcCtD
Alogliptin—Dermatitis—Epirubicin—breast cancer	8.66e-05	0.00107	CcSEcCtD
Alogliptin—Headache—Epirubicin—breast cancer	8.61e-05	0.00106	CcSEcCtD
Alogliptin—Rash—Doxorubicin—breast cancer	8.02e-05	0.000989	CcSEcCtD
Alogliptin—Dermatitis—Doxorubicin—breast cancer	8.01e-05	0.000988	CcSEcCtD
Alogliptin—Headache—Doxorubicin—breast cancer	7.97e-05	0.000982	CcSEcCtD
Alogliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	5.31e-05	0.00155	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	5.31e-05	0.00155	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—MMP1—breast cancer	5.27e-05	0.00154	CbGpPWpGaD
Alogliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	5.23e-05	0.00153	CbGpPWpGaD
Alogliptin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	5.23e-05	0.00153	CbGpPWpGaD
Alogliptin—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	5.22e-05	0.00152	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	5.2e-05	0.00152	CbGpPWpGaD
Alogliptin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	5.16e-05	0.00151	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	5.12e-05	0.0015	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	5.11e-05	0.00149	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—LEP—breast cancer	5.1e-05	0.00149	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—MTR—breast cancer	4.84e-05	0.00141	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—HPGDS—breast cancer	4.74e-05	0.00139	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTT1—breast cancer	4.6e-05	0.00134	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTA3—breast cancer	4.56e-05	0.00133	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	4.51e-05	0.00132	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	4.5e-05	0.00132	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—CYP17A1—breast cancer	4.35e-05	0.00127	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—PTGS1—breast cancer	4.31e-05	0.00126	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	4.3e-05	0.00126	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—CYP17A1—breast cancer	4.3e-05	0.00126	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	4.24e-05	0.00124	CbGpPWpGaD
Alogliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	4.22e-05	0.00123	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—IGF1—breast cancer	4.21e-05	0.00123	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTA4—breast cancer	4.17e-05	0.00122	CbGpPWpGaD
Alogliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	4.16e-05	0.00122	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—NCOA2—breast cancer	4.15e-05	0.00121	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	4.12e-05	0.0012	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—MMP2—breast cancer	4.08e-05	0.00119	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTA2—breast cancer	4.07e-05	0.00119	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—SULT1A1—breast cancer	4.02e-05	0.00117	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	4.01e-05	0.00117	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	3.96e-05	0.00116	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	3.96e-05	0.00116	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTA1—breast cancer	3.92e-05	0.00115	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—NAT2—breast cancer	3.88e-05	0.00113	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	3.83e-05	0.00112	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—CYP3A4—breast cancer	3.73e-05	0.00109	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—CYP3A4—breast cancer	3.68e-05	0.00107	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—CYP1B1—breast cancer	3.67e-05	0.00107	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—CYP1B1—breast cancer	3.62e-05	0.00106	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—NCOA1—breast cancer	3.5e-05	0.00102	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—CYP19A1—breast cancer	3.45e-05	0.00101	CbGpPWpGaD
Alogliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	3.42e-05	0.000999	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—CYP19A1—breast cancer	3.4e-05	0.000993	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CXCL8—breast cancer	3.39e-05	0.00099	CbGpPWpGaD
Alogliptin—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.22e-05	0.000941	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—COMT—breast cancer	3.2e-05	0.000936	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTP1—breast cancer	3.19e-05	0.000932	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—MTR—breast cancer	3.16e-05	0.000924	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—COMT—breast cancer	3.16e-05	0.000924	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTP1—breast cancer	3.15e-05	0.000919	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CTNNB1—breast cancer	3.13e-05	0.000914	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.1e-05	0.000906	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.01e-05	0.000879	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTM1—breast cancer	2.93e-05	0.000856	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	2.89e-05	0.000845	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.85e-05	0.000832	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.82e-05	0.000824	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.81e-05	0.000821	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—CYP1A1—breast cancer	2.78e-05	0.000812	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—CYP2D6—breast cancer	2.76e-05	0.000808	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	2.74e-05	0.000801	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.73e-05	0.000797	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.71e-05	0.000793	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.4e-05	0.0007	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.36e-05	0.000691	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.29e-05	0.000668	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.25e-05	0.000659	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SYNJ2—breast cancer	2.23e-05	0.000653	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.22e-05	0.00065	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—COMT—breast cancer	2.09e-05	0.000612	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.08e-05	0.000609	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NDUFS3—breast cancer	2.08e-05	0.000607	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.07e-05	0.000604	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.06e-05	0.000601	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CHST9—breast cancer	1.95e-05	0.000571	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.92e-05	0.00056	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.89e-05	0.000552	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—COX11—breast cancer	1.85e-05	0.000541	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.82e-05	0.000531	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.79e-05	0.000524	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CDA—breast cancer	1.69e-05	0.000495	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SHMT1—breast cancer	1.69e-05	0.000495	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC2A5—breast cancer	1.63e-05	0.000477	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLCO1B1—breast cancer	1.63e-05	0.000477	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—APRT—breast cancer	1.57e-05	0.00046	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ESRRA—breast cancer	1.48e-05	0.000433	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.48e-05	0.000433	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SYNJ2—breast cancer	1.46e-05	0.000427	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HADHB—breast cancer	1.4e-05	0.00041	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GPI—breast cancer	1.4e-05	0.00041	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NDUFS3—breast cancer	1.36e-05	0.000397	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.34e-05	0.000391	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.34e-05	0.000391	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ADSL—breast cancer	1.28e-05	0.000375	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—FHL2—breast cancer	1.28e-05	0.000375	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PHGDH—breast cancer	1.28e-05	0.000375	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NME1—breast cancer	1.28e-05	0.000375	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—UMPS—breast cancer	1.28e-05	0.000375	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CHST9—breast cancer	1.28e-05	0.000373	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—BRIP1—breast cancer	1.26e-05	0.000368	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—LDHB—breast cancer	1.26e-05	0.000368	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HPSE—breast cancer	1.26e-05	0.000368	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—COX11—breast cancer	1.21e-05	0.000354	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCC1—breast cancer	1.19e-05	0.000349	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTA3—breast cancer	1.19e-05	0.000349	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HMMR—breast cancer	1.19e-05	0.000349	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.16e-05	0.000338	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SHMT1—breast cancer	1.11e-05	0.000324	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CDA—breast cancer	1.11e-05	0.000324	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CA9—breast cancer	1.09e-05	0.000319	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTA4—breast cancer	1.09e-05	0.000319	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.07e-05	0.000312	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC2A5—breast cancer	1.07e-05	0.000312	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GPX2—breast cancer	1.06e-05	0.000311	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTA2—breast cancer	1.06e-05	0.000311	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GPX4—breast cancer	1.05e-05	0.000307	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SULT1A1—breast cancer	1.05e-05	0.000307	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—APRT—breast cancer	1.03e-05	0.000301	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTA1—breast cancer	1.03e-05	0.0003	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—IDH1—breast cancer	1.03e-05	0.0003	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NAT2—breast cancer	1.01e-05	0.000297	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ESRRA—breast cancer	9.68e-06	0.000283	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.68e-06	0.000283	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GPI—breast cancer	9.18e-06	0.000268	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HADHB—breast cancer	9.18e-06	0.000268	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—DPYD—breast cancer	8.9e-06	0.00026	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—MED12—breast cancer	8.9e-06	0.00026	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALDOA—breast cancer	8.76e-06	0.000256	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.75e-06	0.000256	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.75e-06	0.000256	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOA3—breast cancer	8.5e-06	0.000249	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC2A2—breast cancer	8.44e-06	0.000247	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NME1—breast cancer	8.39e-06	0.000245	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—FHL2—breast cancer	8.39e-06	0.000245	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ADSL—breast cancer	8.39e-06	0.000245	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PHGDH—breast cancer	8.39e-06	0.000245	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—UMPS—breast cancer	8.39e-06	0.000245	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CPT1A—breast cancer	8.27e-06	0.000242	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—MTR—breast cancer	8.27e-06	0.000242	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCG2—breast cancer	8.27e-06	0.000242	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—BRIP1—breast cancer	8.23e-06	0.000241	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HPSE—breast cancer	8.23e-06	0.000241	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—LDHB—breast cancer	8.23e-06	0.000241	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HPGDS—breast cancer	8.11e-06	0.000237	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HBA1—breast cancer	8.06e-06	0.000236	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ACHE—breast cancer	7.87e-06	0.00023	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTT1—breast cancer	7.87e-06	0.00023	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCC1—breast cancer	7.8e-06	0.000228	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HMMR—breast cancer	7.8e-06	0.000228	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTA3—breast cancer	7.8e-06	0.000228	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.56e-06	0.000221	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYP17A1—breast cancer	7.45e-06	0.000218	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ENO1—breast cancer	7.37e-06	0.000215	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTGS1—breast cancer	7.37e-06	0.000215	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTA4—breast cancer	7.14e-06	0.000209	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CA9—breast cancer	7.14e-06	0.000209	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOA2—breast cancer	7.1e-06	0.000207	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTA2—breast cancer	6.95e-06	0.000203	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GPX2—breast cancer	6.95e-06	0.000203	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—FASN—breast cancer	6.88e-06	0.000201	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GPX4—breast cancer	6.87e-06	0.000201	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SULT1A1—breast cancer	6.87e-06	0.000201	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—BCHE—breast cancer	6.85e-06	0.0002	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC5A5—breast cancer	6.77e-06	0.000198	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—IDH1—breast cancer	6.71e-06	0.000196	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTA1—breast cancer	6.71e-06	0.000196	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NAT2—breast cancer	6.63e-06	0.000194	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC2A1—breast cancer	6.54e-06	0.000191	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NQO1—breast cancer	6.54e-06	0.000191	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYP3A4—breast cancer	6.38e-06	0.000186	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYP1B1—breast cancer	6.27e-06	0.000183	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.15e-06	0.00018	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOA1—breast cancer	5.98e-06	0.000175	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—STK11—breast cancer	5.89e-06	0.000172	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYP19A1—breast cancer	5.89e-06	0.000172	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—DPYD—breast cancer	5.82e-06	0.00017	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—MED12—breast cancer	5.82e-06	0.00017	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALDOA—breast cancer	5.73e-06	0.000167	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOA3—breast cancer	5.56e-06	0.000162	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC2A2—breast cancer	5.52e-06	0.000161	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—COMT—breast cancer	5.48e-06	0.00016	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTP1—breast cancer	5.45e-06	0.000159	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—MTR—breast cancer	5.41e-06	0.000158	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCG2—breast cancer	5.41e-06	0.000158	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CPT1A—breast cancer	5.41e-06	0.000158	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HMOX1—breast cancer	5.38e-06	0.000157	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ITPR1—breast cancer	5.37e-06	0.000157	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HPGDS—breast cancer	5.3e-06	0.000155	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HBA1—breast cancer	5.27e-06	0.000154	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCB1—breast cancer	5.16e-06	0.000151	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ACHE—breast cancer	5.14e-06	0.00015	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTT1—breast cancer	5.14e-06	0.00015	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—TYMS—breast cancer	5.07e-06	0.000148	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PLA2G4A—breast cancer	5.01e-06	0.000146	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOR1—breast cancer	5.01e-06	0.000146	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTM1—breast cancer	5.01e-06	0.000146	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYP17A1—breast cancer	4.87e-06	0.000142	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTGS1—breast cancer	4.82e-06	0.000141	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ENO1—breast cancer	4.82e-06	0.000141	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GPX1—breast cancer	4.8e-06	0.00014	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYP1A1—breast cancer	4.75e-06	0.000139	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYP2D6—breast cancer	4.73e-06	0.000138	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ERCC2—breast cancer	4.71e-06	0.000138	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOA2—breast cancer	4.64e-06	0.000136	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—FASN—breast cancer	4.5e-06	0.000132	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—BCHE—breast cancer	4.48e-06	0.000131	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—MTHFR—breast cancer	4.43e-06	0.000129	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC5A5—breast cancer	4.43e-06	0.000129	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NQO1—breast cancer	4.27e-06	0.000125	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC2A1—breast cancer	4.27e-06	0.000125	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYP1B1—breast cancer	4.1e-06	0.00012	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CAV1—breast cancer	4.09e-06	0.000119	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.02e-06	0.000117	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOA1—breast cancer	3.91e-06	0.000114	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYP19A1—breast cancer	3.85e-06	0.000113	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—STK11—breast cancer	3.85e-06	0.000113	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CG—breast cancer	3.72e-06	0.000109	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—COMT—breast cancer	3.58e-06	0.000105	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTP1—breast cancer	3.57e-06	0.000104	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HMOX1—breast cancer	3.52e-06	0.000103	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ITPR1—breast cancer	3.51e-06	0.000103	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCB1—breast cancer	3.38e-06	9.86e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—TYMS—breast cancer	3.31e-06	9.69e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.28e-06	9.58e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOR1—breast cancer	3.28e-06	9.58e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTM1—breast cancer	3.28e-06	9.58e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CD—breast cancer	3.27e-06	9.56e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALB—breast cancer	3.23e-06	9.44e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GPX1—breast cancer	3.14e-06	9.17e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYP1A1—breast cancer	3.11e-06	9.08e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NOS3—breast cancer	3.09e-06	9.03e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ERCC2—breast cancer	3.08e-06	9e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—MTHFR—breast cancer	2.9e-06	8.46e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CB—breast cancer	2.85e-06	8.33e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTGS2—breast cancer	2.83e-06	8.26e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CAV1—breast cancer	2.67e-06	7.81e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTEN—breast cancer	2.46e-06	7.2e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.43e-06	7.11e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CD—breast cancer	2.14e-06	6.25e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALB—breast cancer	2.11e-06	6.17e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NOS3—breast cancer	2.02e-06	5.9e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.86e-06	5.45e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTGS2—breast cancer	1.85e-06	5.4e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CA—breast cancer	1.74e-06	5.08e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTEN—breast cancer	1.61e-06	4.71e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—AKT1—breast cancer	1.42e-06	4.15e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CA—breast cancer	1.14e-06	3.32e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—AKT1—breast cancer	9.28e-07	2.71e-05	CbGpPWpGaD
